Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Phospholamban is the regulator of the cardiac sarcoplasmic reticulum (SR) Ca(2+)-ATPase activity and an important modulator of basal contractility in the heart. To determine whether all the SR Ca(2+)-ATPase enzymes are subject to regulation by phospholamban in vivo, transgenic mice were generated which overexpressed phospholamban in the heart, driven by the cardiac-specific alpha-myosin heavy chain promoter. Quantitative immunoblotting revealed a twofold increase in the phospholamban protein levels in transgenic hearts compared to wild type littermate hearts. The transgenic mice showed no phenotypic alterations and no changes in heart/body weight, heart/lung weight, and cardiomyocyte size. Isolated unloaded cardiac myocytes from transgenic mice exhibited diminished shortening fraction (63%) and decreased rates of shortening (64%) and relengthening (55%) compared to wild type (100%) cardiomyocytes. The decreases in contractile parameters of transgenic cardiomyocytes reflected decreases in the amplitude (83%) of the Ca2+ signal and prolongation (131%) in the time for decay of the Ca2+ signal, which was associated with a decrease in the apparent affinity of the SR Ca(2+)-ATPase for Ca2+ (56%), compared to wild type (100%) cardiomyocytes. In vivo analysis of left ventricular systolic function using M mode and pulsed-wave Doppler echocardiography revealed decreases in fractional shortening (79%) and the normalized mean velocity of circumferential shortening (67%) in transgenic mice compared to wild type (100%) mice. The differences in contractile parameters and Ca2+ kinetics in transgenic cardiomyocytes and the depressed left ventricular systolic function in transgenic mice were abolished upon isoproterenol stimulation. These findings indicate that a fraction of the Ca(2+)-ATPases in native SR is not under regulation by phospholamban. Expression of additional phospholamban molecules results in: (a) inhibition of SR Ca2+ transport; (b) decreases in systolic Ca2+ levels and contractile parameters in ventricular myocytes; and (c) depression of basal left ventricular systolic function in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Simplified mammalian DNA isolation procedure
Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., & Berns, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.15.4293 · Cited by 1,494
Enhanced Myocardial Function in Transgenic Mice Overexpressing the β 2 -Adrenergic Receptor
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., & Lefkowitz, R. J. (1994) · Science · doi:10.1126/science.8160017 · Cited by 740
Luo, W., Grupp, I. L., Harrer, J., Ponniah, S., Grupp, G., Duffy, J. J., Doetschman, T., & Kranias, E. G. (1994) · Circulation Research · doi:10.1161/01.res.75.3.401 · Cited by 706
Self-citationTissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.
Subramaniam, A., Jones, W. K., Gulick, J., Wert, S., Neumann, J., & Robbins, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54273-3 · Cited by 469
WLuo, LGrupp, I., JHarrer, SPonniah, GGrupp, JDuffy, J., TDoetschman, & GKranias, E. (1994) · Circulation Research · Cited by 403
Milano, C. A., Dolber, P. C., Rockman, H. A., Bond, R. A., Venable, M. E., Allen, L. F., & Lefkowitz, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10109 · Cited by 371
Lindemann, J. P., Jones, L. R., Hathaway, D. R., Henry, B. G., & Watanabe, A. M. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33279-4 · Cited by 355
Phospholamban Phosphorylation in Intact Ventricles
Wegener, A. D., Simmerman, H. K., Lindemann, J. P., & Jones, L. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60487-9 · Cited by 300
Movsesian, M. A., Nishikawa, M., & Adelstein, R. S. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39680-1 · Cited by 264
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Phospholamban: a crucial regulator of cardiac contractility
MacLennan, D. H., & Kranias, E. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1151 · Cited by 1,088
Self-citationSignaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
Calcium Pumps in Health and Disease
Brini, M., & Carafoli, E. (2009) · Physiological Reviews · doi:10.1152/physrev.00032.2008 · Cited by 676
Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban
Schmitt, J. P., Kamisago, M., Asahi, M., Li, G. H., Ahmad, F., Mende, U., Kranias, E. G., MacLennan, D. H., Seidman, J. G., & Seidman, C. E. (2003) · Science · doi:10.1126/science.1081578 · Cited by 619
Self-citationPhospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function
SIMMERMAN, H. K. B., & JONES, L. R. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.921 · Cited by 574
Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome
Kranias, E. G., & Hajjar, R. J. (2012) · Circulation Research · doi:10.1161/circresaha.111.259754 · Cited by 532
Self-citationCoupling of β2-Adrenoceptor to GiProteins and Its Physiological Relevance in Murine Cardiac Myocytes
Xiao, R.-P., Avdonin, P., Zhou, Y.-Y., Cheng, H., Akhter, S. A., Eschenhagen, T., Lefkowitz, R. J., Koch, W. J., & Lakatta, E. G. (1999) · Circulation Research · doi:10.1161/01.res.84.1.43 · Cited by 387
Phospholamban: A Prominent Regulator of Myocardial Contractility
Koss, K. L., & Kranias, E. G. (1996) · Circulation Research · doi:10.1161/01.res.79.6.1059 · Cited by 353
Self-citationThe cardiac response to exercise in cirrhosis
Wong, F., Girgrah, N., Graba, J., Allidina, Y., Liu, P., & Blendis, L. (2001) · Gut · doi:10.1136/gut.49.2.268 · Cited by 294
Schwinger, R. H. G., Münch, G., Bölck, B., Karczewski, P., Krause, E.-G., & Erdmann, E. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0897 · Cited by 287
Periasamy, M., Bhupathy, P., & Babu, G. J. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm056 · Cited by 259
Type 1 Phosphatase, a Negative Regulator of Cardiac Function
Carr, A. N., Schmidt, A. G., Suzuki, Y., del Monte, F., Sato, Y., Lanner, C., Breeden, K., Jing, S.-L., Allen, P. B., Greengard, P., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4124-4135.2002 · Cited by 259
Self-citationOverexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function
Gergs, U., Boknik, P., Buchwalow, I., Fabritz, L., Matus, M., Justus, I., Hanske, G., Schmitz, W., & Neumann, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405770200 · Cited by 125
Thyroid hormone regulation of phospholamban phosphorylation in the rat heart
Ojamaa, K., Kenessey, A., & Klein, I. (2000) · Endocrinology · doi:10.1210/endo.141.6.7514 · Cited by 106
Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles
Shenoy, R., Klein, I., & Ojamaa, K. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.4.h1690 · Cited by 65
“Studies by Kranias and colleagues (15) have demonstrated the importance of the SERCA2-to-PLB protein ratio in determining cardiomyocyte contractility.”
BackgroundThe enhanced contractility of the phospholamban-deficient mouse heart persists with aging
Slack, J. P., Grupp, I. L., Dash, R., Holder, D., Schmidt, A., Gerst, M. J., Tamura, T., Tilgmann, C., James, P. F., Johnson, R., et al. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1370 · Cited by 64
Self-citation
Metadata
- Authors
- Kadambi, V. J., Ponniah, S., Harrer, J. M., Hoit, B. D., Dorn, G. W., Walsh, R. A., & Kranias, E. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-01-15
- Volume
- 97
- Issue
- 2
- Pages
- 533-539
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2094074899
- Cited by
- 327
- References
- 22
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.